The major goal of the Neuropathology (NP) Core is to provide researchers with well characterized and preserved brain tissue and diagnostic neuropathology evaluations for Alzheimer's Disease (AD) patients and controls. Provision of such tissue is essential to the overall goal of the ADCC to promote strong scientific investigations of AD. In order to achieve this goal, the NP Core will carry out the following specific tasks: 1. obtain brain tissue from AD and control patients who have undergone multiple annual neuropsychological and neurological evaluations prior to death; 2. preserve the tissue in a variety of ways in order to allow application of the most up-to-date technologies by researchers; 3. apply standard criteria for the diagnosis of AD to these brains in a consistent fashion and provide a thorough neuropathological evaluation; 4. maintain an awareness of controversies and evolving standards in the diagnostic criteria; 3. store brain tissue and neuropathological data in a reliable way allowing rapid retrieval; and 6. encourage use of resources of the NP Core by researchers through tissue and data accessibility and accommodation of special preservation protocols. To improve access to well-studied control tissue, the ADCC has established the Religious Orders Study (ROS) Core. The NP Core has begun to obtain brain tissue (19 cases so far) from study subjects who have undergone careful neurological and neuropsychological follow-up. This tissue is likely to be especially valuable in making rigorous clinical- pathological correlations. The NP Core proposes to provide investigators with tissue from this a stereological quantitation of PHF-tau immunostained neuritic plaques and neurofibrillary tangles in the frontal, temporal, and parietal cortices, hippocampus, and entorhinal cortex of-tissue from the ROS core subjects, with the goals of further characterizing the interface between Alzheimer's disease and aging changes in the brain and evaluating stereologic technology as a potential tool to assist in diagnostic classification of this area.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
3P30AG010161-10S1
Application #
6340623
Study Section
Project Start
2000-08-15
Project End
2001-06-30
Budget Start
Budget End
Support Year
10
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Rush University Medical Center
Department
Type
DUNS #
City
Chicago
State
IL
Country
United States
Zip Code
60612
Kovaleva, Mariya A; Bilsborough, Elizabeth; Griffiths, Patricia C et al. (2018) Testing Tele-Savvy: Protocol for a randomized controlled trial. Res Nurs Health 41:107-120
Mahady, L; Nadeem, M; Malek-Ahmadi, M et al. (2018) HDAC2 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer's disease. Neuropathol Appl Neurobiol :
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27
Sekiya, Michiko; Wang, Minghui; Fujisaki, Naoki et al. (2018) Integrated biology approach reveals molecular and pathological interactions among Alzheimer's A?42, Tau, TREM2, and TYROBP in Drosophila models. Genome Med 10:26
Kommaddi, Reddy Peera; Das, Debajyoti; Karunakaran, Smitha et al. (2018) A? mediates F-actin disassembly in dendritic spines leading to cognitive deficits in Alzheimer's disease. J Neurosci 38:1085-1099
Mahady, Laura; Nadeem, Muhammad; Malek-Ahmadi, Michael et al. (2018) Frontal Cortex Epigenetic Dysregulation During the Progression of Alzheimer's Disease. J Alzheimers Dis 62:115-131
Hadjichrysanthou, Christoforos; McRae-McKee, Kevin; Evans, Stephanie et al. (2018) Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies. J Alzheimers Dis 66:587-600
Boyle, Patricia A; Yu, Lei; Wilson, Robert S et al. (2018) Person-specific contribution of neuropathologies to cognitive loss in old age. Ann Neurol 83:74-83
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Wang, Dai; Schultz, Tim; Novak, Gerald P et al. (2018) Longitudinal Modeling of Functional Decline Associated with Pathologic Alzheimer's Disease in Older Persons without Cognitive Impairment. J Alzheimers Dis 62:855-865

Showing the most recent 10 out of 786 publications